Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

STRIDES

Eli Lilly · Phase 2 · Terminated · Enrollment 204

NCT06515418

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
A: Tirzepatide Monotherapyn/rn/rn/rn/rn/r
B: Azelaprag once daily plus Tirzepatiden/rn/rn/rn/rn/r
C: Azelaprag twice daily plus Tirzepatiden/rn/rn/rn/rn/r
D: Azelaprag Monotherapyn/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.